Cargando…

Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses

BACKGROUND: Recent studies have investigated the features of breast cancer (BC) with low human epidermal growth factor receptor 2 (HER2) expression or HER2-0 expression. However, the results were inconsistent. In this study, we investigated the differences in the pathological complete response (pCR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yudi, Lan, Ailin, Dai, Yuran, Jiang, Linshan, Liu, Shengchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162099/ https://www.ncbi.nlm.nih.gov/pubmed/37153867 http://dx.doi.org/10.2147/BCTT.S407896

Ejemplares similares

Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapy
por: Jin, Yudi, et al.
Publicado: (2023)

Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancer
por: Lan, Ailin, et al.
Publicado: (2022)

Breast Metastasis From Rectal Signet-Ring Cell Carcinoma: A Case Report and Review of Literature
por: Dai, Yuran, et al.
Publicado: (2022)

Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy
por: Lan, Ailin, et al.
Publicado: (2023)

Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with Breast Cancer
por: Lan, Ailin, et al.
Publicado: (2023)

Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients
por: Wang, Yihua, et al.
Publicado: (2021)

The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world data
por: Dai, Yuran, et al.
Publicado: (2023)

Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer
por: Xu, Yingkun, et al.
Publicado: (2022)

Functional characterization of two defensins, HlDFS1 and HlDFS2, from the hard tick Haemaphysalis longicornis
por: Sun, Ta, et al.
Publicado: (2017)

Confirmation of anti-DFS70 antibodies is needed in routine clinical samples with DFS staining pattern
por: Mutlu, Esvet, et al.
Publicado: (2016)

Automated Verification of Parallel Nested DFS
por: Oortwijn, Wytse, et al.
Publicado: (2020)

The Nuclear Dense Fine Speckled (DFS) Immunofluorescence Pattern: Not All Roads Lead to DFS70/LEDGFp75
por: Sanchez-Hernandez, Evelyn S., et al.
Publicado: (2023)

Microsoft DFS to CERNBox Home Directories migration
por: Smyrnakis, Apostolos
Publicado: (2020)

Benchmarking / Crosschecking DFS in the ILC Main Linac
por: Smith, Jeffrey C, et al.
Publicado: (2007)

Thrombophilia Associated with Anti-DFS70 Autoantibodies
por: Marlet, Julien, et al.
Publicado: (2015)

Sound Absorption Properties of DFs/EVA Composites
por: Lyu, Lihua, et al.
Publicado: (2019)

Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrate
por: Malyavantham, Kishore, et al.
Publicado: (2017)

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
por: Malyavantham, Kishore S., et al.
Publicado: (2018)

Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study
por: Tang, Lingfeng, et al.
Publicado: (2022)

Effects of Accelerating Structures on On-line DFS in the Main Linac of CLIC
por: Pfingstner, Juergen, et al.
Publicado: (2015)

Deep Flexible Sequential (DFS) Model for Air Pollution Forecasting
por: Kaya, Kıymet, et al.
Publicado: (2020)

Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress
por: Krzemień, Paweł, et al.
Publicado: (2022)

Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity
por: Chen, Dandan, et al.
Publicado: (2022)

Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab
por: Li, Fanfan, et al.
Publicado: (2022)

VISTA H-Score Is Significantly Associated with a 5-Year DFS Rate in Oral Squamous Cell Carcinoma
por: Starzyńska, Anna, et al.
Publicado: (2023)

Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases
por: Sanches, Solange Moraes, et al.
Publicado: (2021)

Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR
por: Dey, Nandini, et al.
Publicado: (2021)

Psychometric properties of the Persian version of delivery fear scale (DFS) in Iran
por: Shakarami, Aazam, et al.
Publicado: (2021)

Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss
por: Bogina, Giuseppe, et al.
Publicado: (2011)

Do anti-DFS70 antibodies temper disease activity and progression in SLE?
por: Choi, May Y, et al.
Publicado: (2021)

Photonics-Based Simultaneous DFS and AOA Measurement System without Direction Ambiguity
por: Meng, Qingqing, et al.
Publicado: (2023)

The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
por: Zhao, Hengqiang, et al.
Publicado: (2021)

Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS
por: Wang, Qiong, et al.
Publicado: (2020)

DFS70/LEDGFp75: An Enigmatic Autoantigen at the Interface between Autoimmunity, AIDS, and Cancer
por: Basu, Anamika, et al.
Publicado: (2015)

Low Prevalence of Anti-DFS70 Antibodies in Children With ANA-Associated Autoimmune Disease
por: Freudenhammer, Mirjam, et al.
Publicado: (2022)

Validation and psychometric properties of the Brazilian-Portuguese dispositional flow scale 2 (DFS-BR)
por: Bittencourt, Ig Ibert, et al.
Publicado: (2021)

The clinical significance of anti-DFS70 autoantibodies and its correlation with Vitamin D levels
por: Duran, Alev Cetin, et al.
Publicado: (2022)

Translation and validation of the Persian version of diabetic foot ulcer scaleshort form (DFS‐SF)
por: Tavassolmand, Sedigheh Sadat, et al.
Publicado: (2022)

Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
por: Howell, Sacha J., et al.
Publicado: (2020)

How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?
por: Norton, Nadine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iogr788cp6pgk1inpa5goob0u1